Community Healthcare Trust Incorporated - Laporan Laba Rugi (TTM)

Community Healthcare Trust Incorporated
DE ˙ DB ˙ US20369C1062
€ 13.30 ↑0.40 (3.10%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Community Healthcare Trust Incorporated menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 72 76 79 84 87 91 93 94 96 98 101 105 109 113 115 115 116 116 117 118
Change (%) 4.55 4.57 5.57 4.68 3.57 2.30 1.47 1.65 2.20 3.78 3.71 3.74 3.47 1.91 -0.26 0.79 0.15 0.64 1.35
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 13 14 14 15 15 15 16 16 16 17 17 18 19 21 22 22 23 23 23 32
Change (%) 4.97 2.84 4.43 3.34 0.33 2.39 1.41 1.75 3.88 4.70 4.16 6.22 7.48 4.43 3.63 2.36 -0.49 1.33 37.54
% of Revenue 17.91 17.99 17.69 17.50 17.27 16.73 16.75 16.74 16.76 17.03 17.18 17.26 17.67 18.36 18.81 19.54 19.85 19.72 19.86 26.95
Gross Operating Profit 59 62 65 69 72 75 77 78 80 81 84 87 90 92 93 92 93 93 93 86
Change (%) 4.45 4.95 5.81 4.96 4.24 2.29 1.48 1.63 1.86 3.59 3.62 3.22 2.61 1.34 -1.16 0.41 0.31 0.47 -7.62
% of Revenue 82.09 82.01 82.31 82.50 82.73 83.27 83.25 83.26 83.24 82.97 82.82 82.74 82.33 81.64 81.19 80.46 80.15 80.28 80.14 73.05
SG&A 8 9 9 10 11 12 13 13 14 15 28 28 16 27 16 17 30 19 20 25
Change (%) 4.39 7.61 10.54 9.73 5.85 3.77 5.70 4.18 7.18 86.87 0.64 -42.80 71.29 -42.62 6.20 78.73 -36.00 2.86 29.58
% of Revenue 11.60 11.59 11.92 12.48 13.08 13.37 13.56 14.13 14.48 15.19 27.35 26.54 14.63 24.23 13.64 14.52 25.76 16.46 16.82 21.51
R&D
Change (%)
% of Revenue
OpEx 46 48 50 53 56 58 59 61 62 64 79 81 73 86 77 80 93 85 86 101
Change (%) 4.40 4.65 6.07 5.70 2.93 2.66 2.49 1.68 3.41 23.11 2.60 -9.44 18.15 -11.00 4.34 16.69 -9.40 1.81 16.90
% of Revenue 63.19 63.10 63.15 63.45 64.07 63.67 63.89 64.54 64.56 65.33 77.49 76.67 66.93 76.43 66.74 69.82 80.83 73.13 73.97 85.33
Operating Income 27 28 29 31 31 33 33 33 34 34 23 25 36 27 38 35 22 31 30 17
Change (%) 4.80 4.44 4.71 2.91 4.71 1.67 -0.34 1.59 -0.02 -32.63 7.53 47.03 -26.25 43.78 -9.48 -35.99 40.42 -2.53 -42.87
% of Revenue 36.81 36.90 36.85 36.55 35.93 36.33 36.11 35.46 35.44 34.67 22.51 23.33 33.07 23.57 33.26 30.18 19.17 26.87 26.03 14.67
Interest Expense -9 -9 -9 -9 -10 -11 -11 -11 -11 -12 -13 -15 -16 -18 -19 -21 -22 -24 -25 -26
Change (%) -4.32 -0.23 6.44 7.90 6.73 3.77 0.16 2.20 6.03 11.51 10.46 11.03 9.58 6.01 9.79 8.06 5.94 5.44 2.42
% of Revenue -12.44 -11.39 -10.87 -10.96 -11.29 -11.64 -11.80 -11.65 -11.72 -12.16 -13.06 -13.91 -14.89 -15.77 -16.40 -18.05 -19.36 -20.47 -21.45 -21.68
Net Income 16 19 20 21 22 22 23 23 23 22 10 11 8 8 18 1 -0 -3 -5 -7
Change (%) 18.86 6.37 5.83 0.67 4.04 0.93 -0.56 1.41 -3.82 -56.52 10.37 -20.64 -8.00 137.24 -92.91 -134.39 613.23 65.20 40.53
% of Revenue 22.17 25.21 25.64 25.70 24.72 24.83 24.50 24.01 23.95 22.54 9.44 10.05 7.69 6.84 15.91 1.13 -0.39 -2.75 -4.51 -6.25

Source: Capital IQ

Other Listings
US:CHCT US$ 15.66
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista